NHI shows weaker metrics with a Zacks Rank #4 (Sell), higher forward P/E ratio of 15.07, higher PEG ratio of 3.83, higher P/B ratio of 2.21, and a lower Value grade of C, indicating it is less attractive for value investors.
National Health Investors news
$66.66−0.27%
Close Sep 29, 2026 · split-adjustedArticles · 30 days1English, de-duplicated
Positive00% of coverage
Neutral00%
Negative1100% of coverage
About National Health Investors
Zacks Investment ResearchAug 31, 11:40 AM ET▼ Negative
BenzingaMay 4, 4:20 PM ET▲ Positive
The company is maintaining its dividend payments at $0.92 per share, demonstrating financial stability and commitment to shareholders. Regular dividend announcements are typically viewed positively as they indicate consistent cash flow generation and management confidence in the business outlook.
Also mentions NHI
Articles that tag NHI but are mainly about other companies.
None recently.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology